Mangiferin monosodium salt attenuates metabolic and alcohol-associated liver disease via a novel insight into cuproptosis and improving gut microbiota
- DOI
- 10.1016/j.taap.2026.118035
- Published
- 2026-11
- Container
- Toxicology and Applied Pharmacology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.taap.2026.118035,
title = {Mangiferin monosodium salt attenuates metabolic and alcohol-associated liver disease via a novel insight into cuproptosis and improving gut microbiota},
author = {Qingqing Zhang and Chongzheng Pang and Lehua Chen and Ruikai Yan and Xue Yu and Baohua Chen and Baoku Li and Chengyan Zhou},
year = {2026},
journal = {Toxicology and Applied Pharmacology},
doi = {10.1016/j.taap.2026.118035},
url = {https://doi.org/10.1016/j.taap.2026.118035}
}RIS
TY - JOUR TI - Mangiferin monosodium salt attenuates metabolic and alcohol-associated liver disease via a novel insight into cuproptosis and improving gut microbiota AU - Qingqing Zhang AU - Chongzheng Pang AU - Lehua Chen AU - Ruikai Yan AU - Xue Yu AU - Baohua Chen AU - Baoku Li AU - Chengyan Zhou PY - 2026 JO - Toxicology and Applied Pharmacology DO - 10.1016/j.taap.2026.118035 UR - https://doi.org/10.1016/j.taap.2026.118035 ER -
APA
Zhang, Q., Pang, C., Chen, L., Yan, R., Yu, X., Chen, B., Li, B., & Zhou, C. (2026). Mangiferin monosodium salt attenuates metabolic and alcohol-associated liver disease via a novel insight into cuproptosis and improving gut microbiota. Toxicology and Applied Pharmacology. https://doi.org/10.1016/j.taap.2026.118035
Source records
- crossref · retrieved 2026-09-26T22:41:50.763Z